Clinical trial
Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic…
NCT00352222 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00352222 |
|---|---|
| Title | Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries |
| Official title | A Prospective, Multicenter, Single Arm Study to Obtain Additional Data on the Safety and Efficacy of the Express Vascular LD Implantation in the Treatment of Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries |
| Acronym | MELODIE |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Collaborators | KIKA |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Disease, Intermittent Claudication, Atherosclerotic Disease, Thrombosis |
| Intervention type | Device |
| Interventions | stent implantation |
| Enrollment | 150 |
| Start date | Jan 1, 2004 |
| Primary completion | Jul 1, 2005 |
| Completion | Feb 1, 2007 |
| First posted | Jul 14, 2006 |
| Last update posted | Sep 29, 2008 |
| Countries | Belgium, Canada, Czechia, Netherlands, Poland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: